Daily Aspirin May Not Prevent First Heart Attack, Stroke

Canadian family physicians warned potential harm of daily dose of aspirin outweighs benefits. Canadians were told to stop using daily aspirin to prevent first stroke or heart attack.

Aspirin intake can not prevent first heart attack or stroke, according to a new research published in Canadian Family Physician.

"This is the most significant practice-changing evidence to come out in the past year," said Michael Kolber, a family medicine professor at the University of Alberta and co-author of the research paper, along with recent University of Calgary family medicine graduate Paul Fritsch.

What is a Heart Attack | How to Prevent Heart Attacks - Myocardial Infarction Smoking
Heart attack is the death of the heart muscle due to loss of blood supply. Simple guidelines to avoid heart attack are listed.

‘Daily Aspirin is no longer recommended for preventing heart attack in patients who never experienced heart attack or stroke. It increases the risk of major internal bleeding, which is higher than preventative benefits.’
Read More..

Kolber and Fritsch reviewed three large, randomized, placebo-controlled studies published in 2018 that showed the risk of major internal bleeding associated with taking an aspirin a day is higher than any preventative benefits.

"These aren't nosebleeds or bleeding gums," Fritsch said. "These are major internal bleeds where the patients need hospitalization and perhaps a blood transfusion, so they're of major clinical, and also personal, significance."

Fritsch said one of the studies also showed an increase in deaths from all causes, and in particular cancer deaths, among the patients who took aspirin, which is also called acetylsalicylic acid or ASA.

The advice to take a daily aspirin to prevent heart disease became dogma in the 1990s but it was based on flawed research, according to Kolber.

In an earlier study, Kolber found that 40 per cent of Albertans over the age of 50 take aspirin to prevent cardiovascular disease, even though most have never had a cardiovascular event. He noted that aspirin is still considered beneficial for those who do have heart disease.

"We really see an aspirin gap," said Kolber. "There are a lot of people taking aspirin for primary prevention who don't need it, and there's a group of people who already have cardiovascular disease who aren't taking it, and they should be."

Kolber advises those who have never had a heart problem to use other preventive measures.

"Instead of just taking a daily aspirin like we've been taught for a generation, we would recommend patients stop smoking, exercise, track their blood pressure and consider the Mediterranean diet."

Kolber said people with elevated future cardiovascular risk might consider taking a statin, which lowers cholesterol.

"The evidence for those measures is far superior to the evidence for aspirin," he said.

Kolber and Fritsch's findings were distributed electronically through Tools for Practice, evidence summaries compiled by the U of A's evidence-based medicine team, PEER (Patients, Experience, Evidence, Research). They are read by 40,000 health-care professionals around the world and funded by the Alberta College of Family Physicians and the Canadian College of Family Physicians.

Source-Eurekalert